Leukocytosis Market Analysis 2025 – Insights For Long-Term Investment & Planning

LONDON, GREATER LONDON, UNITED KINGDOM, June 19, 2025 /EINPresswire.com/ -- The Business Research Company’s Latest Report Explores Market Driver, Trends, Regional Insights - Market Sizing & Forecasts Through 2034

The global Leukocytosis market is forecasted to witness robust growth in the coming years. It is estimated to rise from $4.89 billion in 2024 to $5.17 billion in 2025 at a compound annual growth rate CAGR of 5.7%. This growth during the historical period can be attributed to the increasing incidents of infections, awareness about blood disorders, and rising prevalence of leukemia and other cancers.

What Is The Projected Future Growth Of The Leukocytosis Market Size?
It is projected to escalate to $6.39 billion in 2029 at a compound annual growth rate CAGR of 5.4%. This anticipated upsurge in the forecast period is linked to a higher occurrence of chronic diseases like cancer, a steady demand for early and accurate diagnostic solutions, increasing geriatric population susceptible to immune dysfunction, and a rising awareness among people.

Get Your Free Sample Market Report:
https://www.thebusinessresearchcompany.com/sample.aspx?id=24278&type=smp

What Are The Key Drivers For The Leukocytosis Market?
One of the significant factors propelling the growth of the leukocytosis market is the increasing incidence of blood-related diseases. Blood-related diseases often result in elevated white blood cell counts, a characteristic sign of leukocytosis, thereby necessitating enhanced early diagnosis and effective treatment options. For instance, in 2024, according to the American Cancer Society, there were 62,770 new cases of leukemia reported, which marks an increase from 59,610 cases in 2023.

Who Are The Major Players In The Leukocytosis Market?
Notable companies operating in the Leukocytosis market include McKesson Corporation, Pfizer Inc., Johnson & Johnson, Siemens Healthineers AG, Roche Diagnostics AG, and Bristol Myers Squibb, amongst others.

Order Your Report Now For A Swift Delivery:
https://www.thebusinessresearchcompany.com/report/leukocytosis-global-market-report

Emerging Trends In The Leukocytosis Market?
Companies in the leukocytosis market are progressively focusing on integrating artificial intelligence AI in diagnostic systems. AI technologies like machine learning and natural language processing are being deployed to analyze medical data and bolster the diagnosis of diseases. For instance, in December 2024, Koninklijke Philips NV, launched its CT 5300 system which uses AI technologies to enhance computed tomography CT imaging workflows and improve diagnostic accuracy.

How Is The Leukocytosis Market Segmented?
The leukocytosis market is categorised by:
- Disease Type: Infection, Inflammation, Leukemia, Stress Response
- Diagnosis Type: Blood Tests, Bone Marrow Biopsy, Imaging Techniques
- Distribution Channel: Hospital Pharmacies, Online Pharmacies, Retail Pharmacies
- End User: Hospitals, Diagnostic Laboratories, Research Institutions

Interestingly, the market segment by infection includes bacterial, viral, parasitic, and fungal infections. In Leukemia, segments include Acute Lymphocytic Leukemia ALL, Chronic Lymphocytic Leukemia CLL, Acute Myeloid Leukemia AML, and Chronic Myeloid Leukemia CML.

Where Does The Leukocytosis Market Stand Globally?
In terms of the leukocytosis market share by region, North America accounted for the largest market size in 2024. However, Asia-Pacific is projected to emerge as the fastest-growing region during the forecast period.

Browse Through More Similar Reports By The Business Research Company:

Blood Transfusion Diagnostics Global Market Report 2025
https://www.thebusinessresearchcompany.com/report/blood-transfusion-diagnostics-global-market-report

Stem Cell/Cord Blood Banking Global Market Report 2025
https://www.thebusinessresearchcompany.com/report/stem-cell-cord-blood-banking-global-market-report

Blood Glucose Meters Global Market Report 2025
https://www.thebusinessresearchcompany.com/report/blood-glucose-meters-global-market-report

About The Business Research Company
Learn More About The Business Research Company. With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Contact us at:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 3156230293
Asia +44 2071930708
Europe +44 2071930708
Email us at [email protected]

Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Oliver Guirdham
The Business Research Company
+44 20 7193 0708
[email protected]
Visit us on social media:
LinkedIn
Facebook
X

Legal Disclaimer:

EIN Presswire provides this news content "as is" without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the author above.